acrabstracts.org/abstract/pharmacokinetics-bioavailability-and-safety-of-a-modified-release-once-daily-formulation-of-tofacitinib-in-healthy-volunteers

... study aimed to determine equivalence for extent of exposure between the tofacitinib MR 11 mg vs IR formulation administered as two 5 mg tablets. ... Results: All 26 HV completed the study and were included in the analyses. ... Coleman CI et al. ... Pfizer Inc,. 3;. A. Hazra,. Pfizer Inc,. 1,. Pfizer Inc,. 3;. J. Kushner,. Pfizer Inc,.

clovisoncology.com/media/1046/rucaparib_jledermann_oral_esgo2017.pdf

Nov 7, 2017 ... Columbus, OH, USA; 14Clovis Oncology, Inc., Boulder, CO, USA; 15Foundation ... X. Speakers bureau. Clovis Oncology. X. Pfizer. X. Speakers bureau ... The ARIEL3 phase 3 trial evaluated rucaparib vs placebo following a response to .... 390, Coleman et al, Rucaparib maintenance treatment for recurrent ...

www.bloodjournal.org/content/126/23/745

2 O'Donoghue ML, Ruff CT, Giugliano RP, et al. Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with ... Keshishian: Pfizer Inc.: Consultancy, Other: A. Keshishian is an employee of ... Craig I. Coleman et al., Blood.

courts.delaware.gov/Opinions/Download.aspx?id=284810

Nov 15, 2018 ... Wilmington, Delaware; Mark S. Cheffo, Esq., Hayden A. Coleman, Esq. (Argued),. Debra D. ... Pharma L.P. & The Purdue Frederick Company (“Purdue Pharma"). Michael P. ..... Welfare Fund, et al., v. ... Pfizer Incorporated.

economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-inc-recalls-1-8-million-vials-of-antibiotics/articleshow/64290635.cms

May 23, 2018 ... "Piperacillin and tazobactam have been found to contain elevated levels of impurities that may result in decreased potency," a notification of the ...

www.gibsondunn.com/lawyer/thomas-jeffrey-t

Miotox v. Allergan. This was a dispute over interpretation of a patent license agreement in which plaintiff claimed .... The Coleman Company. .... Pfizer, Inc., et al.

www.pfizersecuritiessettlement.com/docket-files/990694_1.PDF

of All Others Similarly Situated,. Plaintiff vs. PFIZER INC., et al.,. Defendants. ... I am duly licensed to practice before all courts of the State of California and ...... Coleman T.S., “Origins of the Prohibition Against Off-Label Promotion” Food Drug  ...

www.plainsite.org/courts/california-northern-district-court

WELLS FARGO & COMPAY et al · 4:19-cv-01505: Equity Growth Asset Management v. Holden et al · 4:19-cv-01503: v. Mallari Health Systems, Inc. et al  ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0205989

Nov 1, 2018 ... Funding: This study was funded by Bristol-Myers Squibb and Pfizer who ... are employees of Pfizer Inc. with ownership of stocks in Pfizer Inc. S Kamble is an ..... Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V et al. .... Laliberté F, Cloutier M, Nelson WW, Coleman CI, Pilon D, Olson WH, et al.